Global Immune Thrombocytopenia Market Report By Type (Acute Immune Thrombocytopenia And Chronic Immune Thrombocytopenia), By Treatment (Thrombopoietin Receptor Agonists, Immunoglobulins, Corticosteroids And Others); By Distribution Channel (Hospital Pharmacy, Retail Pharmacy And Others) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2019-2026

ID:VMR11211617
February 2020
Report Formats:

The global demand for Immune Thrombocytopenia Market is presumed to reach the valuation of nearly USD XXX MN by 2026 from USD XXX MN in 2019 with a CAGR of X.XX% under the study period of 2020 - 2026.
 
Immune thrombocytopenia is an autoimmune-judged haematological disease affecting the platelets count and quality. It is also referred to as thrombocytopenic purpura which is a rare blood disorder distinguished by the extremely low count of platelet guiding to uncontrollable blood loss. It is labeled as an orphan disorder as there are roughly 0.2 million individuals enduring from the disease symptoms. The immune system of the sufferer with ITP produces antibodies led against platelet antigens and resulting in platelet damage and hindering of platelet generation. This gains the chance of severe bleeding incidents frequently in the patient. The disorder arises when the immune system assaults and damages platelets that help in blood clotting.  Acute ITP lingers less than half a year while the chronic ITP remains for more than a half year. Commonly, adults possess chronic immune thrombocytopenia whereas, teenagers undergo acute disorder.
 
Market Dynamics
 
A surging plurality of immune thrombocytopenia (ITP) has fueled the need of ITP therapeutics. Raised government undertaking to boost the healthcare sector in all countries has indicated favorably on the global immune thrombocytopenia market. Additionally, heightened emphasis on the improvement of drugs and therapeutics is also maintaining an optimistic influence on the market.
 
The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.
 
Additionally, these tools also give inclusive assessment of each application/product segment in the global market of immune thrombocytopenia.
 
Market Segmentation
 
The entire immune thrombocytopenia market has been sub-categorized into type, treatment, and distribution channel. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.
 
By Type

  • Acute Immune Thrombocytopenia
  • Chronic Immune Thrombocytopenia
 
By Treatment
  • Thrombopoietin Receptor Agonists
  • Immunoglobulins
  • Corticosteroids
  • Others
 
By Distribution Channel
  • Hospital Pharmacy
  • Retail Pharmacy
  • Others
 
Regional Analysis
 
This section covers regional segmentation which accentuates on current and future demand for immune thrombocytopenia market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
 
Europe Immune Thrombocytopenia Market By Revenue (USD MN)
 
Europe Immune Thrombocytopenia Market By Revenue
 
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the immune thrombocytopenia market include Amgen Inc., Novartis AG, Rigel Pharmaceuticals, Inc., Dova Pharmaceuticals, Grifols S.A, CSL Limited, Octapharma AG, Intas Pharmaceuticals Ltd. and Saol Therapeutics. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
                                          
 
METHODOLOGY:
 
This market research report has been produced by gathering information on the basis of primary and secondary research. Secondary research has been done by using various sources which include (but not limited to) Company Websites, Paid Data Sources,  Technical Journals, Financial Reports, SEC Filings, and other different industry publications.
 
If specific information is required which is not currently within the scope of the report, it can be provided as a part of customization.

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Immune Thrombocytopenia Market
       2.2. Global Immune Thrombocytopenia Market Snapshot
 
3 . IMMUNE THROMBOCYTOPENIA – INDUSTRY ANALYSIS
       3.1. Introduction
       3.2. Market Drivers of Immune Thrombocytopenia Market
       3.3. Market Restraints of Immune Thrombocytopenia Market
       3.4. Opportunities of Immune Thrombocytopenia Market
       3.5. Trends of Immune Thrombocytopenia Market
       3.6. Porter’s Five Force Analysis of Immune Thrombocytopenia Market
       3.7. Immune Thrombocytopenia Market Attractiveness Analysis
           3.7.1 Market Attractive Analysis by Type
           3.7.2 Market Attractive Analysis by Treatment
           3.7.3 Market Attractive Analysis by Distribution Channel
           3.7.4 Market Attractive Analysis by Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Immune Thrombocytopenia Value Chain Analysis
       4.2. Immune Thrombocytopenia Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Immune Thrombocytopenia Raw Material Manufactures List
           4.2.3. Price Trend of Immune Thrombocytopenia Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 . GLOBAL IMMUNE THROMBOCYTOPENIA MARKET ANALYSIS BY TYPE
       5.1 Overview by Type
       5.2 Global Immune Thrombocytopenia Market Analysis by Type
       5.3 Market Analysis of Acute Immune Thrombocytopenia by Regions
       5.4 Market Analysis of Chronic Immune Thrombocytopenia by Regions
 
6 . GLOBAL IMMUNE THROMBOCYTOPENIA MARKET ANALYSIS BY TREATMENT
       6.1 Overview by Treatment
       6.2 Global Immune Thrombocytopenia Market Analysis by Treatment
       6.3 Market Analysis of Thrombopoietin Receptor Agonists by Regions
       6.4 Market Analysis of Immunoglobulins by Regions
       6.5 Market Analysis of Corticosteroids by Regions
       6.6 Market Analysis of Others by Regions
 
7 . GLOBAL IMMUNE THROMBOCYTOPENIA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
       7.1 Overview by Distribution Channel
       7.2 Global Immune Thrombocytopenia Market Analysis by Distribution Channel
       7.3 Market Analysis of Hospital Pharmacy by Regions
       7.4 Market Analysis of Retail Pharmacy by Regions
       7.5 Market Analysis of Others by Regions
 
8 . GLOBAL IMMUNE THROMBOCYTOPENIA MARKET ANALYSIS BY GEOGRAPHY
       8.1. Regional Outlook
       8.2. Introduction
       8.3. North America
           8.3.1. Overview
           8.3.2. North America Immune Thrombocytopenia Market Estimate by Country
           8.3.3. United State
           8.3.4. Rest of North America
       8.4. Europe
           8.4.1. Overview
           8.4.2. Europe Immune Thrombocytopenia Market Estimate by Market Segment
           8.4.3. Europe Immune Thrombocytopenia Market Estimate by Country
           8.4.4. United Kingdom
           8.4.5. France
           8.4.6. Germany
           8.4.7 Rest of Europe
       8.5. Asia Pacific
           8.5.1. Overview
           8.5.2. Asia Pacific Immune Thrombocytopenia Market Estimate by Market Segment
           8.5.3. Asia Pacific Immune Thrombocytopenia Market Estimate by Country
           8.5.4. China
           8.5.5. Japan
           8.5.6. India
           8.5.7. Rest of Asia Pacific
       8.6. Latin America
           8.6.1. Overview
           8.6.2. Latin America Immune Thrombocytopenia Market Estimate by Market Segment
           8.6.3. Latin America Immune Thrombocytopenia Market Estimate by Country
           8.6.4. Brazil
           8.6.5. Rest of Latin America
       8.7. Middle East & Africa
           8.7.1. Overview
           8.7.2. Middle East & Africa Immune Thrombocytopenia Market Estimate by Market Segment
           8.7.3. Middle East & Africa Immune Thrombocytopenia Market Estimate by Country
           8.7.4. Middle East
           8.7.5. Africa
 
9 . COMPETITIVE LANDSCAPE OF THE IMMUNE THROMBOCYTOPENIA COMPANIES
       9.1. Immune Thrombocytopenia Market Competition
       9.2. Partnership/Collaboration/Agreement
       9.3. Merger And Acquisitions
       9.4. New Product Launch
       9.5. Other Developments
 
10 . COMPANY PROFILES OF IMMUNE THROMBOCYTOPENIA INDUSTRY
       10.1. Company Share Analysis
       10.2. Market Concentration Rate
       10.3. Amgen Inc.
           10.3.1. Company Overview
           10.3.2. Financials
           10.3.3. Products
           10.3.4. Recent Developments
       10.4. Novartis AG
           10.4.1. Company Overview
           10.4.2. Financials
           10.4.3. Products
           10.4.4. Recent Developments
       10.5. Rigel Pharmaceuticals, Inc.
           10.5.1. Company Overview
           10.5.2. Financials
           10.5.3. Products
           10.5.4. Recent Developments
       10.6. Dova Pharmaceuticals
           10.6.1. Company Overview
           10.6.2. Financials
           10.6.3. Products
           10.6.4. Recent Developments
       10.7. Grifols S.A.
           10.7.1. Company Overview
           10.7.2. Financials
           10.7.3. Products
           10.7.4. Recent Developments
       10.8. CSL Limited
           10.8.1. Company Overview
           10.8.2. Financials
           10.8.3. Products
           10.8.4. Recent Developments
       10.9. Octapharma AG
           10.9.1. Company Overview
           10.9.2. Financials
           10.9.3. Products
           10.9.4. Recent Developments
       10.10. Intas Pharmaceuticals Ltd.
           10.10.1. Company Overview
           10.10.2. Financials
           10.10.3. Products
           10.10.4. Recent Developments
       10.11. Saol Therapeutics
           10.11.1. Company Overview
           10.11.2. Financials
           10.11.3. Products
           10.11.4. Recent Developments
 
 *Note - In company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
 
LIST OF TABLES

  • Global Immune Thrombocytopenia Market Snapshot
  • Drivers of The Global Immune Thrombocytopenia Market Impact Analysis
  • Restraints of The Global Immune Thrombocytopenia Market Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Global Immune Thrombocytopenia Market Analysis by Type (USD MN)
  • Global Immune Thrombocytopenia Market Analysis in Acute Immune Thrombocytopenia by Geography (USD MN)
  • Global Immune Thrombocytopenia Market Analysis in Chronic Immune Thrombocytopenia by Geography (USD MN)
  • Global Immune Thrombocytopenia Market Analysis by Treatment (USD MN)
  • Global Immune Thrombocytopenia Market Analysis in Thrombopoietin Receptor Agonists by Geography (USD MN)
  • Global Immune Thrombocytopenia Market Analysis in Immunoglobulins by Geography (USD MN)
  • Global Immune Thrombocytopenia Market Analysis in Corticosteroids by Geography (USD MN)
  • Global Immune Thrombocytopenia Market Analysis in Others by Geography (USD MN)
  • Global Immune Thrombocytopenia Market Analysis by Distribution Channel (USD MN)
  • Global Immune Thrombocytopenia Market Analysis in Hospital Pharmacy by Geography (USD MN)
  • Global Immune Thrombocytopenia Market Analysis in Retail Pharmacy by Geography (USD MN)
  • Global Immune Thrombocytopenia Market Analysis in Others by Geography (USD MN)
  • Global Immune Thrombocytopenia Market by Geography (USD MN)
  • North America Immune Thrombocytopenia Market Analysis by Type (USD MN)
  • North America Immune Thrombocytopenia Market Estimate by Treatment (USD MN)
  • North America Immune Thrombocytopenia Market Estimate by Distribution Channel (USD MN)
  • North America Immune Thrombocytopenia Market Estimate by Country (USD MN)
  • United State Immune Thrombocytopenia Market Analysis by Type (USD MN)
  • United State Immune Thrombocytopenia Market Estimate by Treatment (USD MN)
  • United State Immune Thrombocytopenia Market Analysis by Distribution Channel (USD MN)
  • Rest of North America Immune Thrombocytopenia Market Analysis by Type (USD MN)
  • Rest of North America Immune Thrombocytopenia Market Estimate by Treatment (USD MN)
  • Rest of North America Immune Thrombocytopenia Market Estimate by Distribution Channel(USD MN)
  • Europe Immune Thrombocytopenia Market Analysis by Type (USD MN)
  • Europe Immune Thrombocytopenia Market Estimate by Treatment (USD MN)
  • Europe Immune Thrombocytopenia Market Estimate by Distribution Channel (USD MN)
  • United Kingdom Immune Thrombocytopenia Market Analysis by Type (USD MN)
  • United Kingdom Immune Thrombocytopenia Market Estimate by Treatment (USD MN)
  • United Kingdom Immune Thrombocytopenia Market Estimate by Distribution Channel (USD MN)
  • France Immune Thrombocytopenia Market Analysis by Type (USD MN)
  • France Immune Thrombocytopenia Market Estimate by Treatment (USD MN)
  • France Immune Thrombocytopenia Market Estimate by Distribution Channel (USD MN)
  • Germany Immune Thrombocytopenia Market Analysis by Type (USD MN)
  • Germany Immune Thrombocytopenia Market Estimate by Treatment (USD MN)
  • Germany Immune Thrombocytopenia Market Estimate by Distribution Channel (USD MN)
  • Rest of Europe Immune Thrombocytopenia Market Analysis by Type (USD MN)
  • Rest of Europe Immune Thrombocytopenia Market Estimate by Treatment (USD MN)
  • Rest of Europe Immune Thrombocytopenia Market Estimate by Distribution Channel (USD MN)
  • Asia Pacific Immune Thrombocytopenia Market Analysis by Type (USD MN)
  • Asia Pacific Immune Thrombocytopenia Market Estimate by Treatment (USD MN)
  • Asia Pacific Immune Thrombocytopenia Market Estimate by Distribution Channel (USD MN)
  • Asia Pacific Immune Thrombocytopenia Market Estimate by Country (USD MN)
  • China Immune Thrombocytopenia Market Analysis by Type (USD MN)
  • China Immune Thrombocytopenia Market Estimate by Treatment (USD MN)
  • China Immune Thrombocytopenia Market Estimate by Distribution Channel (USD MN)
  • Japan Immune Thrombocytopenia Market Analysis by Type (USD MN)
  • Japan Immune Thrombocytopenia Market Estimate by Treatment (USD MN)
  • Japan Immune Thrombocytopenia Market Estimate by Distribution Channel (USD MN)
  • India Immune Thrombocytopenia Market Analysis by Type (USD MN)
  • India Immune Thrombocytopenia Market Estimate by Treatment (USD MN)
  • India Immune Thrombocytopenia Market Estimate by Distribution Channel (USD MN)
  • Rest of Asia Pacific Immune Thrombocytopenia Market Analysis by Type (USD MN)
  • Rest of Asia Pacific Immune Thrombocytopenia Market Estimate by Treatment (USD MN)
  • Rest of Asia Pacific Immune Thrombocytopenia Market Estimate by Distribution Channel (USD MN)
  • Latin America Immune Thrombocytopenia Market Analysis by Type (USD MN)
  • Latin America Immune Thrombocytopenia Market Estimate by Treatment (USD MN)
  • Latin America Immune Thrombocytopenia Market Estimate by Distribution Channel (USD MN)
  • Latin America Immune Thrombocytopenia Market Estimate by Country (USD MN)
  • Brazil Immune Thrombocytopenia Market Analysis by Type (USD MN)
  • Brazil Immune Thrombocytopenia Market Estimate by Treatment (USD MN)
  • Brazil Immune Thrombocytopenia Market Estimate by Distribution Channel (USD MN)
  • Rest of Latin America Immune Thrombocytopenia Market Analysis by Type (USD MN)
  • Rest of Latin America Immune Thrombocytopenia Market Estimate by Treatment (USD MN)
  • Rest of Latin America Immune Thrombocytopenia Market Estimate by Distribution Channel (USD MN)
  • Middle East & Africa Immune Thrombocytopenia Market Analysis by Type (USD MN)
  • Middle East & Africa Immune Thrombocytopenia Market Estimate by Treatment (USD MN)
  • Middle East & Africa Immune Thrombocytopenia Market Estimate by Distribution Channel (USD MN)
  • Middle East & Africa Immune Thrombocytopenia Market Estimate by Country (USD MN)
  • Middle East Immune Thrombocytopenia Market Analysis by Type (USD MN)
  • Middle East Immune Thrombocytopenia Market Estimate by Treatment (USD MN)
  • Middle East Immune Thrombocytopenia Market Estimate by Distribution Channel (USD MN)
  • Africa Immune Thrombocytopenia Market Analysis by Type (USD MN)
  • Africa Immune Thrombocytopenia Market Estimate by Treatment (USD MN)
  • Africa Immune Thrombocytopenia Market Estimate by Distribution Channel (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton
  • New Product Launch
  • Other Developments
  • Company Market Share Analysis, 2019
 
LIST OF FIGURES
 
  • Research Scope of Immune Thrombocytopenia Report
  • Market Research Process
  • Market Research Methodology
  • Global Immune Thrombocytopenia Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Type
  • Market Attractiveness Analysis by Treatment
  • Market Attractiveness Analysis by Distribution Channel
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Immune Thrombocytopenia Market Analysis by Type (USD MN)
  • Global Immune Thrombocytopenia Market Analysis in Acute Immune Thrombocytopenia by Geography (USD MN)
  • Global Immune Thrombocytopenia Market Analysis in Chronic Immune Thrombocytopenia by Geography (USD MN)
  • Global Immune Thrombocytopenia Market Analysis by Treatment (USD MN)
  • Global Immune Thrombocytopenia Market Analysis in Thrombopoietin Receptor Agonists by Geography (USD MN)
  • Global Immune Thrombocytopenia Market Analysis in Immunoglobulins by Geography (USD MN)
  • Global Immune Thrombocytopenia Market Analysis in Corticosteroids by Geography (USD MN)
  • Global Immune Thrombocytopenia Market Analysis in Others by Geography (USD MN)
  • Global Immune Thrombocytopenia Market Analysis by Distribution Channel (USD MN)
  • Global Immune Thrombocytopenia Market Analysis in Hospital Pharmacy by Geography (USD MN)
  • Global Immune Thrombocytopenia Market Analysis in Retail Pharmacy by Geography (USD MN)
  • Global Immune Thrombocytopenia Market Analysis in Others by Geography (USD MN)
  • Latin America Immune Thrombocytopenia Market by Revenue
  • Middle East & Africa Immune Thrombocytopenia Market by Revenue
  • Recent Development in Immune Thrombocytopenia Industry
  • Company Market Share Analysis, 2019
 
* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials